For Immediate Release: October 2, 2025 | Contact: [email protected]
WASHINGTON, DC – Concerned Women for America (CWA) said that the Food and Drug Administration (FDA) should not have approved another generic version of the abortion pill, mifepristone, as this dangerous drug will put more women at risk given that generic drugs are cheaper and more easily accessible.
“The FDA is supposed to be doing a safety and efficacy review of the abortion drug mifepristone. Instead, they have approved a new generic version of the drug, allowing more women to conduct DIY abortions and thus putting lives at risk. Young women taking an abortion pill alone in their room with no medical supervision and access to medical care if there are complications can be fatal. Our government should be rejecting drugs that kill unborn children and put women’s lives at risk, not approving them. We hope the FDA will reconsider its approval,” said Penny Nance, CEO and President, Concerned Women for America.
Mifepristone is used to terminate a pregnancy up to ten weeks, but the lack of medical oversight and access to emergency medical assistance can be fatal to young women taking it alone and late in pregnancy. This drug blocks the mother’s natural production of progesterone for her child, cutting off blood and nourishment to the baby. The unborn child begins to starve to death. Between 24-48 hours later, the woman takes Misoprostol, which causes the mother to contract and bleed to force the child out of the womb.
“CWA has been fighting against the FDA’s illegal, politically-motivated, mishandling of the approval of these dangerous drugs for decades, and we won’t stop fighting for women’s safety until the FDA takes full responsibility and treats the matter with the seriousness women deserve,” said Nance.
##
Concerned Women for America, the largest public policy women’s organization, is dedicated to promoting Biblical values and Constitutional principles in public policy. More information is available at www.ConcernedWomen.org.
To arrange an interview with CWA, please contact Kelly Oliver at (703) 307-9404 or [email protected].
